Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pharmacology|December 29, 1995
In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptorsS D Kivlighn, G J Zingaro, R A Gabel, et al.Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.American Journal of Hypertension|January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996S D Kivlighn, G J Zingaro, R A Gabel, et al.Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Phenylacetamides as selective alpha-1A adrenergic receptor antagonistsM A Patane, R M DiPardo, R C Newton, et al.Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-onesP G Nantermet, J C Barrow, H G Selnick, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonistsJ B Nerenberg, J M Erb, W J Thompson, et al.Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine seriesW C Wong, W Sun, B Lagu, et al.Journal of Medicinal Chemistry|July 14, 2000
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasiaJ C Barrow, P G Nantermet, H G Selnick, et al.Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinonesD Nagarathnam, S W Miao, B Lagu, et al.Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moietyT G Murali Dhar, D Nagarathnam, M R Marzabadi, et al.Pageof 2